Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.00
Ask:
1.20
Spread: 0.20 (20.00%)
Market Cap: £9.41m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Notice of AGM

8 Jun 2026 07:00

RNS Number : 2708H
Tern PLC
08 June 2026
Β 

8 June 2026

Β 

Tern Plc

Β 

("Tern" or the "Company")

Β 

Notice of AGM

Β 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, announces that the Company's Annual General Meeting ("AGM") will be held at 9.30am on Tuesday 30 June 2026 at the offices of Allenby Capital, 5 St Helen's Place, London, EC3A 6AB.

Β 

The notice of AGM (the "Notice of AGM") is available on the Company's website https://www.ternplc.com/investors and has been posted to shareholders, together with the form of proxy.

Β 

Extracts from the Notice of AGM

Β 

The AGM is required to be held by 30 June 2026 to meet the Company's Companies Act 2006 obligations. As the Company's Report and Accounts for the Year Ended 31 December 2025 (the "Accounts") have not yet been published, it is proposed that a separate general meeting (the "General Meeting") will be held to approve certain resolutions including approval of the Accounts. It is currently expected that the General Meeting will be convened in due course for the earlier of 10.00 am or immediately following the AGM on 30 June 2026.

Β 

Details of the resolutions to be proposed at the AGM (the "Resolutions") are set out below and in the Notice of AGM. The Resolutions cover ordinary business, granting the directors of the Company (the "Directors") the authority to issue new ordinary shares of Β£0.0002 each ("Ordinary Shares") generally (Resolution 1), together with special business to grant the directors the authority to issue new Ordinary Shares for cash whilst dis-applying the statutory pre-emption rights of existing shareholders ("Shareholders") in relation to such an issue (Resolution 2) (with resolutions 1 and 2 being the "Share Issuance Resolutions"), and to conduct share buy-backs (Resolution 3).

Β 

The Share Issuance Resolutions would permit the Directors to issue up to 175,000,000 new Ordinary Shares (representing approximately 20.5 per cent. of the Company's existing issued ordinary share capital) generally and, of those, up to 75,000,000 new Ordinary Shares (representing approximately 8.8 per cent. of the Company's existing issued ordinary share capital) for cash whilst dis-applying the statutory pre-emption rights of Shareholders in relation to such an issue.

Β 

Recommendation

Β 

The Directors consider that the proposed Resolutions are in the interests of the Company and of its shareholders as a whole. Accordingly, they unanimously recommend that you vote in favour of the Resolutions to be proposed at the AGM, as the Directors and members of Tern's senior management team intend to do in respect of their own beneficial shareholdings amounting to 24,733,699 Ordinary Shares, representing approximately 2.89 per cent. of the issued ordinary share capital of the Company.

Β 

Capitalised terms used, but not otherwise defined in this announcement, bear the meanings ascribed to them in the Notice of AGM.

Β 

Enquiries

Β 

Tern Plc

Jane McCracken (Interim Non-Executive Chair)

via IFC Advisory

Β 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Ashur Joseph (Corporate Finance)

Kelly Gardiner (Sales and Corporate Broking)

Β 

Tel: 0203 328 5656

Β 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Staton

Β 

Tel: 0203 934 6632

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NOAUVRNRNOUNRAR
Date   Source Headline
23rd Jun 20267:00 amRNSResults for the year ended 31 December 2025
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.